MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 563163 | Name: MG-262

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MG-262 is a modulator of the Ubiquitin Proteasome System (UPS), as well as a selective proteasome inhibitor.

Chemical Structure

MG-262
MG-262
CAS#179324-22-2

Theoretical Analysis

MedKoo Cat#: 563163

Name: MG-262

CAS#: 179324-22-2

Chemical Formula: C25H42BN3O6

Exact Mass: 491.3167

Molecular Weight: 491.43

Elemental Analysis: C, 61.10; H, 8.61; B, 2.20; N, 8.55; O, 19.53

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
MG-262; MG 262; MG262; Z-LLL-boronate; Z-LLL-B(OH)2; Z-Leu-Leu-Leu-B(OH)2; PS-III; PS III; PSIII;
IUPAC/Chemical Name
((5S,8S,11R)-5,8-diisobutyl-13-methyl-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-11-yl)boronic acid
InChi Key
MWKOOGAFELWOCD-FKBYEOEOSA-N
InChi Code
InChI=1S/C25H42BN3O6/c1-16(2)12-20(24(31)29-22(26(33)34)14-18(5)6)27-23(30)21(13-17(3)4)28-25(32)35-15-19-10-8-7-9-11-19/h7-11,16-18,20-22,33-34H,12-15H2,1-6H3,(H,27,30)(H,28,32)(H,29,31)/t20-,21-,22-/m0/s1
SMILES Code
O=C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](B(O)O)CC(C)C)=O)=O)CC(C)C)OCC1=CC=CC=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 491.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Chung JK, Spencer E, Hunt M, McCauley T, Welty D. Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs. J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):224-232. doi: 10.1089/jop.2017.0106. Epub 2017 Dec 21. PubMed PMID: 29267138; PubMed Central PMCID: PMC5963635. 2: Ghezzi C, Calmettes G, Morand P, Ribalet B, John S. Real-time imaging of sodium glucose transporter (SGLT1) trafficking and activity in single cells. Physiol Rep. 2017 Feb;5(3). pii: e13062. doi: 10.14814/phy2.13062. PubMed PMID: 28193781; PubMed Central PMCID: PMC5309568. 3: Li J, Zhou C, Li J, Wan Y, Li T, Ma P, Wang Y, Sang H. Gene expression profiling of CD133-positive cells in coronary artery disease. Mol Med Rep. 2015 Nov;12(5):7512-6. doi: 10.3892/mmr.2015.4359. Epub 2015 Sep 24. PubMed PMID: 26458356. 4: Agyin JK, Santhamma B, Roy SS. Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma. Bioorg Med Chem Lett. 2013 Dec 1;23(23):6455-8. doi: 10.1016/j.bmcl.2013.09.043. Epub 2013 Sep 21. PubMed PMID: 24119559; PubMed Central PMCID: PMC3836429. 5: Pujols L, Fernández-Bertolín L, Fuentes-Prado M, Alobid I, Roca-Ferrer J, Agell N, Mullol J, Picado C. Proteasome inhibition reduces proliferation, collagen expression, and inflammatory cytokine production in nasal mucosa and polyp fibroblasts. J Pharmacol Exp Ther. 2012 Oct;343(1):184-97. doi: 10.1124/jpet.111.190710. Epub 2012 Jul 11. PubMed PMID: 22787116. 6: Takezawa J, Aiba N, Kajiwara K, Yamada K. Caffeine abolishes the ultraviolet-induced REV3 translesion replication pathway in mouse cells. Int J Mol Sci. 2011;12(12):8513-29. doi: 10.3390/ijms12128513. Epub 2011 Nov 29. PubMed PMID: 22272088; PubMed Central PMCID: PMC3257085. 7: Huang H, Chen D, Li S, Li X, Liu N, Lu X, Liu S, Zhao K, Zhao C, Guo H, Yang C, Zhou P, Dong X, Zhang C, Guanmei, Dou QP, Liu J. Gambogic acid enhances proteasome inhibitor-induced anticancer activity. Cancer Lett. 2011 Feb 28;301(2):221-8. doi: 10.1016/j.canlet.2010.12.015. Epub 2011 Jan 7. PubMed PMID: 21216092; PubMed Central PMCID: PMC3662239. 8: Huang H, Zhang X, Li S, Liu N, Lian W, McDowell E, Zhou P, Zhao C, Guo H, Zhang C, Yang C, Wen G, Dong X, Lu L, Ma N, Dong W, Dou QP, Wang X, Liu J. Physiological levels of ATP negatively regulate proteasome function. Cell Res. 2010 Dec;20(12):1372-85. doi: 10.1038/cr.2010.123. Epub 2010 Aug 31. PubMed PMID: 20805844; PubMed Central PMCID: PMC2996470. 9: Tang M, Li J, Huang W, Su H, Liang Q, Tian Z, Horak KM, Molkentin JD, Wang X. Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc Res. 2010 Dec 1;88(3):424-33. doi: 10.1093/cvr/cvq217. Epub 2010 Jul 2. PubMed PMID: 20601385; PubMed Central PMCID: PMC2972684. 10: Westphal K, Stangl V, Fähling M, Dreger H, Weller A, Baumann G, Stangl K, Meiners S. Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic Biol Med. 2009 Dec 1;47(11):1652-60. doi: 10.1016/j.freeradbiomed.2009.09.017. Epub 2009 Sep 17. PubMed PMID: 19766714. 11: Osmulski PA, Hochstrasser M, Gaczynska M. A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel. Structure. 2009 Aug 12;17(8):1137-47. doi: 10.1016/j.str.2009.06.011. PubMed PMID: 19679091; PubMed Central PMCID: PMC2746003. 12: Abu-Saad K, Shai I, Kaufman-Shriqui V, German L, Vardi H, Fraser D. Bread type intake is associated with lifestyle and diet quality transition among Bedouin Arab adults. Br J Nutr. 2009 Nov;102(10):1513-22. doi: 10.1017/S0007114509990675. Epub 2009 Jul 7. PubMed PMID: 19580699. 13: Perez M, Santa-Maria I, Gomez de Barreda E, Zhu X, Cuadros R, Cabrero JR, Sanchez-Madrid F, Dawson HN, Vitek MP, Perry G, Smith MA, Avila J. Tau--an inhibitor of deacetylase HDAC6 function. J Neurochem. 2009 Jun;109(6):1756-66. doi: 10.1111/j.1471-4159.2009.06102.x. Epub 2009 May 7. PubMed PMID: 19457097. 14: Ludwig A, Fechner M, Wilck N, Meiners S, Grimbo N, Baumann G, Stangl V, Stangl K. Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system. J Mol Med (Berl). 2009 Aug;87(8):793-802. doi: 10.1007/s00109-009-0469-9. Epub 2009 Apr 28. PubMed PMID: 19399470. 15: Oussaief L, Hippocrate A, Clybouw C, Rampanou A, Ramirez V, Desgranges C, Vazquez A, Khelifa R, Joab I. Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent. Virology. 2009 Apr 25;387(1):41-9. doi: 10.1016/j.virol.2009.02.009. Epub 2009 Feb 28. PubMed PMID: 19254802. 16: Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schönthal AH. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009 Jun 4;113(23):5927-37. doi: 10.1182/blood-2008-07-171389. Epub 2009 Feb 3. PubMed PMID: 19190249. 17: Wang WX, Kong BH, Li P, Song K, Qu X, Cui BX, Jiang J, Zhang YZ, Yang XS. [Effect of extracellular signal regulated kinase signal pathway on apoptosis induced by MG262 in ovarian cancer cells]. Zhonghua Fu Chan Ke Za Zhi. 2008 Sep;43(9):690-4. Chinese. PubMed PMID: 19087521. 18: Wiberg K, Carlson K, Aleskog A, Larsson R, Nygren P, Lindhagen E. In vitro activity of bortezomib in cultures of patient tumour cells--potential utility in haematological malignancies. Med Oncol. 2009;26(2):193-201. doi: 10.1007/s12032-008-9107-6. Epub 2008 Nov 18. PubMed PMID: 19016012. 19: Takezawa J, Ishimi Y, Yamada K. Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells. Cancer Sci. 2008 May;99(5):863-71. doi: 10.1111/j.1349-7006.2008.00764.x. Epub 2008 Feb 24. PubMed PMID: 18294277. 20: Meiners S, Dreger H, Fechner M, Bieler S, Rother W, Günther C, Baumann G, Stangl V, Stangl K. Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Hypertension. 2008 Feb;51(2):302-8. Epub 2007 Dec 17. PubMed PMID: 18086945.